1082.45 24.45 (2.31%)

New 52W Low in past week

1.6M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

US FDA Approval
Aurobindo Pharma gets US FDA approval to produce Rivaroxaban tablets with a market size of $8.5 bn See details


Aurobindo Pharma Ltd. Earnings/Conference Calls

Aurobindo Pharma Ltd. earnings concalls and investor presentations

1240 Votes:
Buy 80.16%
Sell 13.79%
Hold 6.05%
BUY
SELL
HOLD